Home › Funds › Birchview Capital, LP › VALN

Birchview Capital, LP position in VALN

VALNEVA SE · Health Care

Birchview Capital, LP reported holding 201,390 shares of VALN (VALNEVA SE) in its Q3 2026 13F filing — a position valued at US$1.2M, representing 0.74% of its reported portfolio and ranking #34 among its reported holdings. Birchview Capital, LP first reported this position in Q3 2026.

Latest position (Q3 2026)201.39K sh
Reported value held$1.25M
Portfolio Weight0.74%
First reportedQ3 2026
Last changeNew
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Birchview Capital, LP's VALN position evolved

Birchview Capital, LP first disclosed a stake in VALN in Q3 2026 at 201,390 shares (US$1.2M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 201.39K $1.25M New

About VALN and 13F data

VALN (VALNEVA SE) is a Health Care company. 25 other funds we track also report a position in VALN — the largest reported positions include Frazier Life Sciences Management, L.P. (US$12.0M), Vivo Capital, LLC (US$4.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VALN

All VALN fund holders →

FAQ

How long has Birchview Capital, LP held VALN?

Birchview Capital, LP has disclosed VALN holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Birchview Capital, LP's current position in VALN?

As of Q3 2026, Birchview Capital, LP holds 201.39K shares of VALN (VALNEVA SE), valued at $1.25M, representing 0.74% of its reported portfolio and ranking #34.

Has Birchview Capital, LP been buying or selling VALN?

In the latest 13F filing (Q3 2026), Birchview Capital, LP newly opened its position in VALN.

Which other funds hold VALN?

Other major institutional holders of VALN include Frazier Life Sciences Management, L.P., Vivo Capital, LLC, among 25 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.